iZafe Group AB (publ)
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a IZAFE-B.ST research report →
Companywww.izafe.se
iZafe Group AB (publ), a life-science company, engages in the research, development, and marketing of digital medical solutions and services for safer drug management at home. The company provides Dosell, an automated drug dispenser that handles dose bags, facilitates and enables independent medication, and reminds and alerts if the current dose is not taken at the right time. It serves consumers, and public and private-sector care providers in Sweden, the Nordic region, and internationally.
- CEO
- Anders Segerstrom
- IPO
- 2011
- Employees
- 7
- HQ
- Stockholm, SE
Price Chart
Valuation
- Market Cap
- $136.82M
- P/E
- -6.73
- P/S
- 19.29
- P/B
- 5.33
- EV/EBITDA
- -9.16
- Div Yield
- 0.00%
Profitability
- Gross Margin
- -48.65%
- Op Margin
- -275.39%
- Net Margin
- -273.15%
- ROE
- -123.02%
- ROIC
- -66.35%
Growth & Income
- Revenue
- $5.99M · -24.68%
- Net Income
- $-16,675,999 · 18.69%
- EPS
- $-0.05 · 33.47%
- Op Income
- $-18,390,000
- FCF YoY
- 100.00%
Performance & Tape
- 52W High
- $0.80
- 52W Low
- $0.23
- 50D MA
- $0.38
- 200D MA
- $0.47
- Beta
- -0.06
- Avg Volume
- 826.10K
Get TickerSpark's AI analysis on IZAFE-B.ST
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our IZAFE-B.ST Coverage
We haven't published any research on IZAFE-B.ST yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate IZAFE-B.ST Report →